To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Expression Analysis Signs Agreement to Provide Genotyping Services to GSK
Expression Analysis, Inc. has entered into an agreement with GlaxoSmithKline to provide microarray based genotyping services.
"We are pleased to support GSK microarray-based genotyping requirements," said Steve McPhail, President and CEO of Expression Analysis.
"Expression Analysis has developed the expertise and infrastructure to provide our pharmacogenomic clients with significant value based on our knowledge of microarray-based technology and the dedication of our staff to providing high-quality results."
"This agreement advances our goal of supporting pharmacogenomic studies in clinical trials."
